- NCT00210535
- Primary Citation
- Data Specification Not Available
Trial Information
Generic NameTopiramateProduct NameTOPAMAX®Therapeutic AreaNervous System DiseasesEnrollment110% Female61%% White85%
Product ClassAnticonvulsantsSponsor Protocol NumberTOPMATMIG3006Data PartnerJohnson & JohnsonCondition StudiedMigraine DisordersMean/Median Age (Years)14.2
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available